| Product Code: ETC5244770 | Publication Date: Nov 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Artificial-coma-medically-induced-drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Artificial-coma-medically-induced-drug Market - Industry Life Cycle |
3.4 Israel Artificial-coma-medically-induced-drug Market - Porter's Five Forces |
3.5 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Artificial-coma-medically-induced-drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidences of traumatic brain injuries and other critical conditions requiring artificial coma induction |
4.2.2 Technological advancements in the field of medical devices and monitoring systems for artificial coma patients |
4.2.3 Growing investments in healthcare infrastructure and facilities in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulations and ethical considerations surrounding the use of medically-induced artificial comas |
4.3.2 Limited awareness among healthcare professionals and patients about the benefits and risks associated with artificial coma induction |
5 Israel Artificial-coma-medically-induced-drug Market Trends |
6 Israel Artificial-coma-medically-induced-drug Market Segmentations |
6.1 Israel Artificial-coma-medically-induced-drug Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Propofol, 2021-2031F |
6.1.3 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Barbiturate, 2021-2031F |
6.2 Israel Artificial-coma-medically-induced-drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Status Epilepticus, 2021-2031F |
6.2.3 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Stroke, 2021-2031F |
6.2.4 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Traumatic Brain Injury, 2021-2031F |
6.2.5 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Brain Infections, 2021-2031F |
6.2.6 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Drug Overdose, 2021-2031F |
6.2.7 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Others, 2021-2031F |
6.3 Israel Artificial-coma-medically-induced-drug Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Israel Artificial-coma-medically-induced-drug Market Revenues & Volume, By Drug Stores & Retail Pharmacies, 2021-2031F |
7 Israel Artificial-coma-medically-induced-drug Market Import-Export Trade Statistics |
7.1 Israel Artificial-coma-medically-induced-drug Market Export to Major Countries |
7.2 Israel Artificial-coma-medically-induced-drug Market Imports from Major Countries |
8 Israel Artificial-coma-medically-induced-drug Market Key Performance Indicators |
8.1 Average length of stay in artificial coma for patients |
8.2 Rate of successful awakenings from artificial coma |
8.3 Adoption rate of new monitoring technologies for artificial coma patients |
9 Israel Artificial-coma-medically-induced-drug Market - Opportunity Assessment |
9.1 Israel Artificial-coma-medically-induced-drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Artificial-coma-medically-induced-drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Artificial-coma-medically-induced-drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Artificial-coma-medically-induced-drug Market - Competitive Landscape |
10.1 Israel Artificial-coma-medically-induced-drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Artificial-coma-medically-induced-drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here